Foresite Capital Fund VI LP 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 6:03 pm Sale | 2025-12-31 | 13G | CASI PHARMACEUTICALS HLDGS INC CASIF | Foresite Capital Fund VI LP | 0 0.000% | -979,956 (Position Closed) | Filing |
| 2025-11-14 4:05 pm Purchase | 2025-09-30 | 13G | CASI PHARMACEUTICALS HLDGS INC CASIF | Foresite Capital Fund VI LP | 979,956 6.300% | 192,835 (+24.50%) | Filing |
| 2025-08-12 4:05 pm Sale | 2025-06-30 | 13G | CASI PHARMACEUTICALS HLDGS INC CASIF | Foresite Capital Fund VI LP | 787,121 5.100% | -522,262 (-39.89%) | Filing |
| 2024-06-20 9:00 pm Purchase | 2024-06-10 | 13G | CASI PHARMACEUTICALS HLDGS INC CASIF | Foresite Capital Fund VI LP | 1,309,383 9.800% | 1,309,383 (New Position) | Filing |